Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T.
Inoue Y, et al. Among authors: uto t.
J Cancer Res Clin Oncol. 2023 Jul;149(7):2963-2974. doi: 10.1007/s00432-022-04193-w. Epub 2022 Jul 14.
J Cancer Res Clin Oncol. 2023.
PMID: 35834011